Fifth Third Bancorp’s Accelerate Diagnostics AXDX Stock Holding History

Fifth Third Bancorp’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3	Closed	-$1K	–	2168
2019 Q2	$1K	Buy	+3	New	+$587	﹤0.01%	2179

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Fifth Third Bancorp's AXDX Position: Q3 2019 in Review

Fifth Third Bancorp sold out of Accelerate Diagnostics (AXDX) in Q3 2019, closing a stake of 3 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in AXDX in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 113 funds tracked by Wall St. Rank hold AXDX as of Q3 2019.

Fifth Third Bancorp reported no remaining Accelerate Diagnostics position as of Q3 2019 after selling out during the quarter.
Fifth Third Bancorp sold 3 Accelerate Diagnostics shares in Q3 2019, an estimated $1K.
Fifth Third Bancorp first reported a position in Accelerate Diagnostics in Q2 2019 and held it in 1 quarter.
Fifth Third Bancorp's Accelerate Diagnostics position peaked at $1K in Q2 2019.
113 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2019.

Based on Fifth Third Bancorp's 13F filing for Q3 2019, filed 14 Nov 2019.